EE201300007A - Kombineeritud ravimkoostis diabeedi ning ainevahetush„irete raviks - Google Patents

Kombineeritud ravimkoostis diabeedi ning ainevahetush„irete raviks

Info

Publication number
EE201300007A
EE201300007A EEP201300007A EEP201300007A EE201300007A EE 201300007 A EE201300007 A EE 201300007A EE P201300007 A EEP201300007 A EE P201300007A EE P201300007 A EEP201300007 A EE P201300007A EE 201300007 A EE201300007 A EE 201300007A
Authority
EE
Estonia
Prior art keywords
diabetes
treatment
pharmaceutical composition
metabolic disorders
combined pharmaceutical
Prior art date
Application number
EEP201300007A
Other languages
English (en)
Inventor
Iliich Epshtein Oleg
Original Assignee
Iliich Epshtein Oleg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44899155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE201300007(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010130348/15A external-priority patent/RU2531048C2/ru
Priority claimed from RU2011127051/15A external-priority patent/RU2509572C2/ru
Application filed by Iliich Epshtein Oleg filed Critical Iliich Epshtein Oleg
Publication of EE201300007A publication Critical patent/EE201300007A/et
Publication of EE05761B1 publication Critical patent/EE05761B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP201300007A 2010-07-21 2011-07-15 Kombineeritud ravimkoostis diabeedi ning ainevahetushäirete raviks EE05761B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2010130348/15A RU2531048C2 (ru) 2010-07-21 2010-07-21 Лекарственное средство для уменьшения резистентности к инсулину и лечения сахарного диабета и способ повышения эффективности лечения сахарного диабета инсулином и/или гипогликемическими препаратами
RU2011127051/15A RU2509572C2 (ru) 2011-07-01 2011-07-01 Лекарственное средство для уменьшения резистентности к инсулину и для лечения сахарного диабета, способ уменьшения резистентности к инсулину, способ лечения сахарного диабета и способ лечения сахарного диабета инсулином и/или гипогликемическими препаратами
PCT/IB2011/002177 WO2012010966A2 (en) 2010-07-21 2011-07-15 A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders

Publications (2)

Publication Number Publication Date
EE201300007A true EE201300007A (et) 2013-08-15
EE05761B1 EE05761B1 (et) 2016-03-15

Family

ID=44899155

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP201300007A EE05761B1 (et) 2010-07-21 2011-07-15 Kombineeritud ravimkoostis diabeedi ning ainevahetushäirete raviks

Country Status (29)

Country Link
US (1) US8617555B2 (et)
EP (2) EP3693018A1 (et)
JP (2) JP2013533268A (et)
KR (2) KR20130103486A (et)
CN (1) CN103118707A (et)
AR (1) AR082312A1 (et)
AU (1) AU2011281240B2 (et)
BR (1) BR112013001299A2 (et)
CA (1) CA2805961A1 (et)
CL (1) CL2013000200A1 (et)
CZ (1) CZ2013124A3 (et)
DE (1) DE112011102396T5 (et)
DK (1) DK201370089A (et)
EA (1) EA029847B1 (et)
EE (1) EE05761B1 (et)
ES (1) ES2445846R1 (et)
FI (1) FI20135152L (et)
FR (1) FR2962913A1 (et)
GB (2) GB2552405B (et)
IT (1) ITTO20110627A1 (et)
LT (1) LT5980B (et)
MX (1) MX2013000804A (et)
MY (1) MY160979A (et)
NO (1) NO20130265A1 (et)
NZ (1) NZ606964A (et)
PE (1) PE20130815A1 (et)
SE (1) SE1350212A1 (et)
SG (1) SG187578A1 (et)
WO (1) WO2012010966A2 (et)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
EA200802440A1 (ru) * 2006-06-06 2009-06-30 Олег Ильич ЭПШТЕЙН Лекарственное средство для лечения ожирения, сахарного диабета и заболеваний с нарушением толерантности к глюкозе
BR112013000841A2 (pt) 2010-07-15 2016-06-07 Oleg Lliich Epshtein composições farmacêuticas, métodos de tratamento da obesidade e distúrbios metabólicos relacionados, de redução da massa corpórea de mamífero, do crescimento da massa corpórea de mamífero, do consumo de comida em mamífero, de trtamento de paciente de adicção de substância psicoativa, de adicção de substância psicoativa e uso de forma ativada-potencializada de anticorpo para receptor de canabinoide humano.
ES2440393R1 (es) * 2010-07-15 2014-10-10 Oleg Iliich Epshtein Un método para aumentar el efecto de una forma activada potenciada de un anticuerpo
EP2593474A2 (en) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
MX2013000807A (es) 2010-07-21 2013-10-28 Oleg Iliich Epshtein Un metodo para el tratamiento del trastorno de hiperactividad con deficit de atencion.
AU2011281247B2 (en) * 2010-07-21 2015-07-30 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
DE112011102397T5 (de) * 2010-07-21 2013-05-08 Oleg Iliich Epshtein Pharmazeutische Kombinationszusammensetzungen und Verfahren zur Behandlung von Schwindel, Kinetose und vegetativ-vaskulärer Dystonie
EA030513B1 (ru) * 2010-08-06 2018-08-31 Олег Ильич ЭПШТЕЙН Комбинированная фармацевтическая композиция и способ лечения и профилактики инфекционных заболеваний
TWI588153B (zh) * 2012-05-18 2017-06-21 中國醫藥大學 多胜肽、編碼該多胜肽之核酸分子、以及該多胜肽之應用
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
US5811437A (en) * 1996-05-21 1998-09-22 Eli Lilly And Company Methods of increasing nitric oxide synthesis
US6150500A (en) * 1996-07-12 2000-11-21 Salerno; John C. Activators of endothelial nitric oxide synthase
WO1999026657A1 (en) * 1997-11-25 1999-06-03 Musc Foundation For Research Development Inhibitors of nitric oxide synthase
US6933272B1 (en) * 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
EP1534302A4 (en) * 2002-08-22 2009-01-07 Nutrition 21 Inc ARGININILICATE / INOSITOL COMPLEX AND ITS USE
TWI345470B (en) 2003-03-14 2011-07-21 Nutrition Res Inc Homeopathic formulations useful for treating pain and/or inflammation
WO2005067928A1 (en) * 2004-01-20 2005-07-28 Astellas Pharma Inc. Method for treating erectile dysfunction
RU2438707C2 (ru) * 2006-06-06 2012-01-10 Олег Ильич Эпштейн Лекарственное средство для перорального лечения сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе, и способ получения твердой лекарственной формы для пероральной терапии сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе
EA200802440A1 (ru) * 2006-06-06 2009-06-30 Олег Ильич ЭПШТЕЙН Лекарственное средство для лечения ожирения, сахарного диабета и заболеваний с нарушением толерантности к глюкозе
GB0812019D0 (en) * 2008-07-02 2008-08-06 Asterion Ltd Insulin
BR112013000841A2 (pt) * 2010-07-15 2016-06-07 Oleg Lliich Epshtein composições farmacêuticas, métodos de tratamento da obesidade e distúrbios metabólicos relacionados, de redução da massa corpórea de mamífero, do crescimento da massa corpórea de mamífero, do consumo de comida em mamífero, de trtamento de paciente de adicção de substância psicoativa, de adicção de substância psicoativa e uso de forma ativada-potencializada de anticorpo para receptor de canabinoide humano.
EP2593474A2 (en) * 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
ES2440393R1 (es) * 2010-07-15 2014-10-10 Oleg Iliich Epshtein Un método para aumentar el efecto de una forma activada potenciada de un anticuerpo
AU2011281247B2 (en) * 2010-07-21 2015-07-30 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
DE112011102397T5 (de) * 2010-07-21 2013-05-08 Oleg Iliich Epshtein Pharmazeutische Kombinationszusammensetzungen und Verfahren zur Behandlung von Schwindel, Kinetose und vegetativ-vaskulärer Dystonie

Also Published As

Publication number Publication date
NZ606964A (en) 2015-08-28
GB2496799A (en) 2013-05-22
LT5980B (lt) 2013-12-27
MY160979A (en) 2017-03-31
EE05761B1 (et) 2016-03-15
US20130064824A1 (en) 2013-03-14
FR2962913A1 (fr) 2012-01-27
GB201707872D0 (en) 2017-06-28
NO20130265A1 (no) 2013-04-18
MX2013000804A (es) 2013-10-28
CN103118707A (zh) 2013-05-22
KR20180127515A (ko) 2018-11-28
FI20135152L (fi) 2013-02-21
SE1350212A1 (sv) 2013-04-22
EA029847B1 (ru) 2018-05-31
EA201300124A1 (ru) 2013-12-30
ITTO20110627A1 (it) 2012-01-22
PE20130815A1 (es) 2013-07-18
GB2496799B (en) 2017-11-22
AU2011281240A1 (en) 2013-03-07
DK201370089A (en) 2013-02-19
CZ2013124A3 (cs) 2013-06-12
LT2013018A (lt) 2013-10-25
ES2445846R1 (es) 2015-01-02
EP2595658A2 (en) 2013-05-29
WO2012010966A3 (en) 2012-03-29
JP2013533268A (ja) 2013-08-22
JP2016222684A (ja) 2016-12-28
US8617555B2 (en) 2013-12-31
AR082312A1 (es) 2012-11-28
CL2013000200A1 (es) 2015-01-23
GB201302924D0 (en) 2013-04-03
BR112013001299A2 (pt) 2017-11-21
DE112011102396T5 (de) 2013-05-02
GB2552405B (en) 2018-05-30
AU2011281240B2 (en) 2016-07-07
WO2012010966A2 (en) 2012-01-26
KR20130103486A (ko) 2013-09-23
SG187578A1 (en) 2013-03-28
ES2445846A2 (es) 2014-03-05
CA2805961A1 (en) 2012-01-26
GB2552405A (en) 2018-01-24
EP3693018A1 (en) 2020-08-12

Similar Documents

Publication Publication Date Title
EE201300007A (et) Kombineeritud ravimkoostis diabeedi ning ainevahetush„irete raviks
IL257581A (en) New dihydropyrimidineisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
EP2528603A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS
IL223286A0 (en) Piperidine derivatives and their use for the treatment of metabolic disorders
ZA201304822B (en) Azetidine derivatives useful for the treatment of metabolic and inflimmatory diseases
IL223289A0 (en) Treatment of type 2 diabetes
EP2900266A4 (en) TOLL-LIKE RECEPTOR-3 ANTAGONISTS FOR THE TREATMENT OF METABOLISM AND CARDIAC DISEASES
IL235058A0 (en) Pharmaceutical combinations for the treatment of metabolic disorders
CO6801718A2 (es) Composición terapéutica para el tratamiento de glioblastoma
SMT201500005B (it) Composizione framaceutica inalabile
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks
BR112013015048A2 (pt) composição para o tratamento de distúrbios metabólicos
HK1257401A1 (zh) 用於治療糖尿病和相關病症的方法和組合物
EP2755685A4 (en) TOLL-LIKE RECEPTOR-3 ANTAGONISTS FOR THE TREATMENT OF METABOLISM AND CARDIAC DISEASES
GB201006167D0 (en) Compounds for the treatment of metabolic disorders
IL234616A0 (en) A herbal preparation for the treatment of metabolic diseases
EP2402342A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING TYPE 2 DIABETES
EP2600716A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF METABOLISM DISEASES
GB201006166D0 (en) Compounds for the treatment of metabolic disorders
EP2755671A4 (en) COMBINATION OF PTEROSTILS AND STATINE FOR THE TREATMENT OF METABOLISM DISEASES, CARDIOVASCULAR DISEASES AND INFLAMMATION
IT1403064B1 (it) Composizione di sostanze per il trattamento di pazienti con ipercolesterolemia e patologie collegate
EP2646046A4 (en) COMPOSITIONS AND METHODS FOR TREATING NERVOUS DISORDER IN CONNECTION WITH DIABETES
GB201019482D0 (en) Compounds for the treatment of metabolic disorders
GB201006164D0 (en) Compounds for the treatment of metabolic disorders

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20180715